Pharma Industry News

FiercePharmaAsia—Lantus biosimilar, Takeda’s Zika vaccine, Celltrion warning letter

Written by David Miller

Mylan and Biocon won an EU recommendation for approval of a Lantus biosimilar, Takeda’s Zika vaccine candidate won FDA fast-track status, Celltrion's South Korean plant was slapped with a warning letter, and more.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]